Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
Lilliana Oliveira, Russell D CohenThe Department of Medicine, Section of Gastroenterology, University of Chicago Medical Center, Chicago, IL, USAAbstract: The aminosalicylates (5-ASA; also referred to as mesalamine-based agents) are considered as first-line in the maintenance of remission of mild to...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-02-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/maintaining-remission-in-ulcerative-colitis-ndash-role-of-once-daily-e-a6453 |